SPONSOR
IRCCS SYNLAB SDN
Total Trials
2
Recruiting
2
Phases
N/A
Conditions studied: Renal StonesOsteometabolic DiseaseAtherosclerosis and Calcific Aortic Stenosis with and Without Diabetes
IRCCS SYNLAB SDN is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Renal Stones, Osteometabolic Disease, Atherosclerosis and Calcific Aortic Stenosis with and Without Diabetes.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — IRCCS SYNLAB SDN
How many clinical trials has IRCCS SYNLAB SDN sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by IRCCS SYNLAB SDN, of which 2 are actively recruiting participants. These trials cover conditions including Renal Stones, Osteometabolic Disease, Atherosclerosis and Calcific Aortic Stenosis with and Without Diabetes. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does IRCCS SYNLAB SDN research focus on?
IRCCS SYNLAB SDN clinical trials span Renal Stones, Osteometabolic Disease, Atherosclerosis and Calcific Aortic Stenosis with and Without Diabetes. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a IRCCS SYNLAB SDN clinical trial?
To participate in a IRCCS SYNLAB SDN trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all IRCCS SYNLAB SDN trials with current recruitment status updated daily.
Clinical Trials by IRCCS SYNLAB SDN
NCT06869603
Recruiting
Evaluation of Adherence to the Mediterranean Diet in Patients with Recurrent Renal Stones and Disease Osteometabolic
Renal Stones
NCT06337227
Recruiting
Potential Role of Sirtuins As Epigenetic Biomarkers of the Patient with Atherosclerosis or Calcific Aortic Stenosis
Atherosclerosis and Calcific Aortic Stenosis with and Without Diabetes
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology